The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients

Aim: Hypothermia is a rare complication of antipsychotic drugs but serious outcomes including death may result. In this study, we aimed to investigate body temperature alterations in acute phase of chlorpromazine treatment, the relationship of inflammatory indicators and risk factors for hypothermic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ates Duman, Mehmet Ali Baş, Faruk Çiçekci, Jale Bengi Çelik, Bülent Devrim Akçay, Muhammed Emin Zora, Ömür İlban
Format: Article
Language:English
Published: Selcuk University Press 2022-12-01
Series:Genel Tıp Dergisi
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/2428787
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563605901770752
author Ates Duman
Mehmet Ali Baş
Faruk Çiçekci
Jale Bengi Çelik
Bülent Devrim Akçay
Muhammed Emin Zora
Ömür İlban
author_facet Ates Duman
Mehmet Ali Baş
Faruk Çiçekci
Jale Bengi Çelik
Bülent Devrim Akçay
Muhammed Emin Zora
Ömür İlban
author_sort Ates Duman
collection DOAJ
description Aim: Hypothermia is a rare complication of antipsychotic drugs but serious outcomes including death may result. In this study, we aimed to investigate body temperature alterations in acute phase of chlorpromazine treatment, the relationship of inflammatory indicators and risk factors for hypothermic effect in intensive care unit (ICU) patients. Materials and methods: 63 intensive care patients who needed sedative treatment due to agitation were divided into two groups as Group 1 (n = 30) with temperatures ≤ 38°C, and Group 2 (n = 33) with temperatures > 38°C according to baseline body temperatures. Also, recurrent measurements for 12 hours were made at specific intervals following 25 mg intravenous chlorpromazine. Results: In Group 1, decrease in body temperatures was significant from 4th to 12th hours (p < 0.01), while in Group 2, significant decreases in body temperatures at all measurement hours were observed (p < 0.01). Temperature changes (delta temperature) observed at specific measurement intervals were significantly higher in Group 2 compared to Group 1. That difference was statistically significant at all intervals except for ΔTemperature B-6 (p < 0.05). The odds of hypothermic effects by chlorpromazine were 16%, 46%, 3%, and 18% for Acute Physiology and Chronic Health Evaluation II, procalcitonin, C-reactive protein, and white blood cells, respectively. Conclusion: Chlorpromazine treatment applied for agitation in ICU patients was associated with acute hypothermic effect. Severity of disease and comorbidities might increase risk of hypothermia, and inflammatory biomarkers might be predictors of adverse drug reaction.
format Article
id doaj-art-33362149e2cf4eccadf890b028289a18
institution Kabale University
issn 2602-3741
language English
publishDate 2022-12-01
publisher Selcuk University Press
record_format Article
series Genel Tıp Dergisi
spelling doaj-art-33362149e2cf4eccadf890b028289a182025-01-02T23:43:04ZengSelcuk University PressGenel Tıp Dergisi2602-37412022-12-0132665866510.54005/geneltip.1116922154The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit PatientsAtes Duman0Mehmet Ali Baş1Faruk Çiçekci2Jale Bengi Çelik3Bülent Devrim Akçay4Muhammed Emin Zora5Ömür İlban6SELÇUK ÜNİVERSİTESİSELÇUK ÜNİVERSİTESİSELÇUK ÜNİVERSİTESİSELÇUK ÜNİVERSİTESİSAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE TIP FAKÜLTESİSELÇUK ÜNİVERSİTESİSELÇUK ÜNİVERSİTESİAim: Hypothermia is a rare complication of antipsychotic drugs but serious outcomes including death may result. In this study, we aimed to investigate body temperature alterations in acute phase of chlorpromazine treatment, the relationship of inflammatory indicators and risk factors for hypothermic effect in intensive care unit (ICU) patients. Materials and methods: 63 intensive care patients who needed sedative treatment due to agitation were divided into two groups as Group 1 (n = 30) with temperatures ≤ 38°C, and Group 2 (n = 33) with temperatures > 38°C according to baseline body temperatures. Also, recurrent measurements for 12 hours were made at specific intervals following 25 mg intravenous chlorpromazine. Results: In Group 1, decrease in body temperatures was significant from 4th to 12th hours (p < 0.01), while in Group 2, significant decreases in body temperatures at all measurement hours were observed (p < 0.01). Temperature changes (delta temperature) observed at specific measurement intervals were significantly higher in Group 2 compared to Group 1. That difference was statistically significant at all intervals except for ΔTemperature B-6 (p < 0.05). The odds of hypothermic effects by chlorpromazine were 16%, 46%, 3%, and 18% for Acute Physiology and Chronic Health Evaluation II, procalcitonin, C-reactive protein, and white blood cells, respectively. Conclusion: Chlorpromazine treatment applied for agitation in ICU patients was associated with acute hypothermic effect. Severity of disease and comorbidities might increase risk of hypothermia, and inflammatory biomarkers might be predictors of adverse drug reaction.https://dergipark.org.tr/tr/download/article-file/2428787adverse drug reactionbody temperature changeschlorpromazineintensive care unitpsychomotor agitation
spellingShingle Ates Duman
Mehmet Ali Baş
Faruk Çiçekci
Jale Bengi Çelik
Bülent Devrim Akçay
Muhammed Emin Zora
Ömür İlban
The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
Genel Tıp Dergisi
adverse drug reaction
body temperature changes
chlorpromazine
intensive care unit
psychomotor agitation
title The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
title_full The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
title_fullStr The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
title_full_unstemmed The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
title_short The Acute Effect of Chlorpromazine on Body Temperature in Intensive Care Unit Patients
title_sort acute effect of chlorpromazine on body temperature in intensive care unit patients
topic adverse drug reaction
body temperature changes
chlorpromazine
intensive care unit
psychomotor agitation
url https://dergipark.org.tr/tr/download/article-file/2428787
work_keys_str_mv AT atesduman theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT mehmetalibas theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT farukcicekci theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT jalebengicelik theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT bulentdevrimakcay theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT muhammedeminzora theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT omurilban theacuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT atesduman acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT mehmetalibas acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT farukcicekci acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT jalebengicelik acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT bulentdevrimakcay acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT muhammedeminzora acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients
AT omurilban acuteeffectofchlorpromazineonbodytemperatureinintensivecareunitpatients